Nemanja Damjanov Selected Research

PF-06651600

10/2020

Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nemanja Damjanov Research Topics

Disease

24	Rheumatoid Arthritis 10/2020 - 02/2009
5	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 11/2006
5	Infections 10/2020 - 03/2009
4	Rheumatic Diseases (Rheumatism) 03/2019 - 03/2014
4	Arthritis (Polyarthritis) 11/2017 - 03/2009
3	Nausea 04/2020 - 11/2006
3	Pain (Aches) 08/2018 - 09/2009
3	Inflammation (Inflammations) 12/2012 - 05/2009
2	digital ulcers 01/2022 - 01/2018
2	Anemia 04/2020 - 03/2010
2	Herpes Zoster 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 03/2014
2	Disease Progression 12/2018 - 03/2009
2	Psoriatic Arthritis 02/2018 - 03/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018 - 03/2009
2	Fatigue 01/2018 - 05/2011
2	Chronic Disease (Chronic Diseases) 01/2018 - 09/2013
2	Ankylosing Spondylitis 05/2016 - 03/2009
2	Necrosis 03/2014 - 03/2009
2	Synovitis 03/2012 - 01/2012
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2011 - 05/2011
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Herpes Simplex 10/2020
1	Skin Diseases (Skin Disease) 10/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2020
1	Headache (Headaches) 04/2020
1	Fibrosis (Cirrhosis) 02/2020
1	Axial Spondyloarthritis 09/2019
1	Stroke (Strokes) 01/2019
1	Pulmonary Embolism 01/2019
1	Ruptured Aneurysm 01/2019
1	Shoulder Pain 08/2018
1	Tendinopathy (Tendonitis) 08/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Hemorrhage 05/2016
1	Mevalonate Kinase Deficiency 01/2015
1	Fever (Fevers) 01/2015
1	Myocarditis (Carditis) 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Cardiogenic Shock 01/2015
1	Edema (Dropsy) 01/2015
1	Exanthema (Rash) 01/2015
1	Skin Neoplasms (Skin Cancer) 03/2014
1	Melanoma (Melanoma, Malignant) 03/2014

Drug/Important Bio-Agent (IBA)

10	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 02/2009
7	Antirheumatic Agents (DMARD)IBA 01/2019 - 03/2009
6	Etanercept (Enbrel)FDA Link 02/2018 - 06/2013
5	Pharmaceutical PreparationsIBA 01/2019 - 05/2011
5	Biological ProductsIBA 05/2016 - 03/2009
3	Adalimumab (Humira)FDA Link 04/2020 - 03/2014
3	Interleukin-6 (Interleukin 6)IBA 09/2018 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 02/2020 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 02/2020 - 05/2009
2	upadacitinibIBA 01/2020 - 01/2019
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 03/2019 - 03/2012
2	GlucocorticoidsIBA 08/2018 - 01/2018
2	Prostaglandins AIBA 02/2018 - 09/2013
2	ametantrone (HAQ)IBA 01/2018 - 09/2013
2	SteroidsIBA 01/2017 - 05/2011
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 05/2016 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 03/2009
2	Tumor Necrosis Factor InhibitorsIBA 03/2014 - 12/2012
2	CytokinesIBA 12/2012 - 05/2011
2	Histone Deacetylase InhibitorsIBA 05/2011 - 05/2011
2	p38 Mitogen-Activated Protein KinasesIBA 05/2009 - 02/2009
1	FibrinIBA 01/2022
1	Thrombin FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2020
1	PF-06651600IBA 10/2020
1	Tec protein-tyrosine kinaseIBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2020
1	fenebrutinibIBA 04/2020
1	Platelet-Derived Growth FactorIBA 02/2020
1	Oxidoreductases (Dehydrogenase)IBA 02/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2020
1	Matrix Metalloproteinases (MMPs)IBA 02/2020
1	Antifibrotic AgentsIBA 02/2020
1	NADP (NADPH)IBA 02/2020
1	Janus KinasesIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Betamethasone (Celestone)FDA Link 08/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017
1	EnzymesIBA 01/2017
1	SBI-087IBA 12/2016
1	RNA (Ribonucleic Acid)IBA 10/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2016
1	tocilizumab (atlizumab)FDA Link 03/2014
1	Abatacept (Orencia)FDA Link 03/2014
1	Infliximab (Remicade)FDA Link 03/2014
1	Biosimilar PharmaceuticalsIBA 03/2014
1	Rituximab (Mabthera)FDA Link 03/2014
1	Certolizumab Pegol FDA Link 03/2014
1	golimumab FDA Link 03/2014
1	Interleukin-17 (Interleukin 17)IBA 12/2012
1	Peptides (Polypeptides)IBA 05/2012
1	AntibodiesIBA 05/2012

Therapy/Procedure

12	Therapeutics 10/2020 - 11/2006
3	Biological Therapy 09/2019 - 03/2009
1	Injections 08/2018